I have written several articles on Dr. Fauci. A list of the links have been provided at the bottom of this article for your convenience. This article will, however address different aspects on Dr. Fauci’s career.
There has been a lot of conflicting information on the drug Hydroxychloroquine. One wonders if Dr. Birx or Dr. Fauci and not President Trump endorsed it, would there be so much negative press on it? Frankly the whole issue has really irritated the shit out of me. I can’t believe that politicians and other individuals in positions of power are willing to let countless people die just to keep their political positions or to oust President Trump from office. That is some cold and heartless shit. I know I am using profanity, but I am really very angry. I frankly believe that the FDA, Big Pharma and Dr. Fauci are playing God. They basically are choosing who will live and who will die by the decisions they are making.
The Drug Hydroxychloroquine was approved for medical use in the United States in 1955. It is on the World Health Organization’s List of Essential Medicines. In 2017, it was the 128th most commonly prescribed medication in the United States, with more than five million prescriptions. It is sold under the Brand name Plaquenil, and is used to treat malaria, rheumatoid arthritis, lupus and pophyria cutanea tarda. Common side effects may include vomiting, headache, changes in vision, and muscle weakness. Severe side effects may include allergic reactions, vision problems, and heart problems. Common side effects may include vomiting, headache, changes in vision, and muscle weakness. Severe side effects may include allergic reactions, vision problems, and heart problems(long QT or QT prologation). Hydroxychloroquine and chloroquine are extremely toxic in overdose. Serious symptoms of overdose generally occur within an hour of ingestion. These symptoms may include sleepiness, vision changes, seizures, coma, stopping of breathing, and heart problems such as ventricular fibrillation and low blood pressure. Although all risks cannot be excluded, it remains a treatment for rheumatic disease during pregnancy. Hydroxychloroquine is in the antimalarial and 4-aminoquinoline families of medication.Although all risk cannot be excluded, it remains a treatment for rheumatic disease during pregnancy. Hydroxychloroquine is in the antimalarial and 4-aminoquinoline families of medication. Typical dosing is 200mg twice a day for a total of 5 to10 days for the treatment of covid-19. This is well below the threshold considered dangerous, and 5 to 10 days can hardly be considered chronic usage.
While every prescription medication has adverse effects, hydroxychloroquine is no different. However, most or all of these adverse effects are the result of chronic usage with large doses, typically for treating rheumatoid arthritis or lupus. Rheumatologists have been prescribing this medication for decades. It is considered so safe that they don’t even monitor the patient’s heart rhythm.
On June 15, 2020 the FDA revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation in a clinical trial was not feasible. The agency determined that the legal criteria for issuing an EUA are no longer met. Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA. Additionally, in light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorized use. This is the statutory standard for issuance of an EUA. The Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services originally requested the EUA covering chloroquine and hydroxychloroquine, and the FDA granted the EUA on March 28, 2020 based on the science and data available at the time. Today, in consultation with the FDA, BARDA sent a letter to the FDA requesting revocation of the EUA based on up to date science and data.The FDA has a responsibility to regularly review the appropriateness of an EUA, and as such, the agency will review emerging information associated with the emergency uses for the authorized products. Recent results from a large randomized clinical trial in hospitalized patients, a population similar to the population for which chloroquine and hydroxychloroquine were authorized for emergency use, demonstrated that hydroxychloroquine showed no benefit on mortality or in speeding recovery. This outcome was consistent with other new data, including data showing that the suggested dosing regimens for chloroquine and hydroxychloroquine are unlikely to kill or inhibit the virus that causes COVID-19. The totality of scientific evidence currently available indicate a lack of benefit.
“While additional clinical trials continue to evaluate the potential benefit of these drugs in treating or preventing COVID-19, we determined the emergency use authorization was no longer appropriate. This action was taken following a rigorous assessment by scientists in our Center for Drug Evaluation and Research,” said Patrizia Cavazzoni, M.D., acting director of the FDA’s Center for Drug Evaluation. “We remain committed to using every tool at our disposal in collaboration with innovators and researchers to provide sick patients timely access to appropriate new therapies. Our decisions will always be based on objective and rigorous evaluation of the scientific data.This will never change.”
Chloroquine and hydroxychloroquine are both FDA-approved to treat or prevent malaria. Hydroxychloroquine is also approved to treat autoimmune conditions such as chronic discoid lupus erythematosus, systemic lupus erythematosus in adults, and rheumatoid arthritis. Both drugs have been prescribed for years to help patients with these debilitating, or even deadly, diseases, and FDA has determined that these drugs are safe and effective when used for these diseases in accordance with their FDA-approved labeling. Of note, FDA approved products may be prescribed by physicians for off-label uses if they determine it is appropriate for treating their patients, including during COVID.
The FDA made this action sound innocent, but by pulling the EUA, they basically ended the use of this medication. If doctors chose to prescribe this medication, they are doing so without the support of the FDA. They are using it off-label. While this practice takes place in the medical profession it is hardly common place. Also I find it amazing that is perfectly safe to use Hydroxychloroquine for other treatments, but it is wholly unsafe in the treatment of covid-19. To my way of thinking this action was taken strictly for political reasons. There was simply no medical justification for it.
We know why Big Pharma doesn’t want Hydroxychloroquine to be the covid drug of choice, there simply is no money in it. A 100 pills sells for $37. Zinc the third drug of the treatment triad is available over the counter, and azithromycin the second drug is one of the cheapest antibiotics in the market today. While the drug touted by Dr. Fauci, Remdesivir is basically a new unproven antiviral drug, which is not approved anywhere globally for any use. Guess what the course of treatment will cost, $3,100. For the Hydroxy triad treatment we are looking at about $20.00 for a complete 5 day dosage. You wonder why big pharma is so hot for Remdesivir? Oh, by the way did I forget to mention that Dr. Fauci has a vested interest in Remdesivir, my bad.
Newly Published Outpatient Study Finds that Early Use of Zinc, Hydroxychloroquine and Azithromycin Is Associated with Less Hospitalizations and Death
NEW YORK, July 15, 2020 /PRNewswire/ — Dr. Vladimir Zelenko, a New York based primary care physician, announced that a retrospective analysis based on his patient data is available to read online at www.thezelenkoprotocol.com. The study, which has been submitted for peer review, found that early intervention and treatment of risk stratified COVID-19 patients in the outpatient setting resulted in five times less hospitalizations and deaths. The medications used in the treatment approach were zinc, low dose hydroxychloroquine, and azithromycin.
Prior studies of COVID-19 treatments have been largely based on severely ill patients in the hospital. This study examines outcomes of patients treated after their first visit to the doctor’s office. Using simple risk stratification criteria, Dr. Zelenko identified which patients required prescriptions for the triple drug therapy, and prescribed these medications for five days.
“These three medications are affordable, available in pill form, and work in synergy against COVID-19,” said Zelenko. “Hydroxychloroquine’s main function within this treatment approach is to allow zinc to enter the cell. Zinc is the virus killer, and azithromycin prevents secondary bacterial infection in the lungs and reduces the risk of pulmonary complications.”
“The world seems to have forgotten common medical knowledge: that we want to treat any patient with an infectious disease as soon as possible,” said Derwand. “What differentiates this study is that patients were prescribed these medications early, in the outpatient setting. Dr. Zelenko treated his risk stratified patients immediately and didn’t wait for the disease to intensify.”
“The well-tolerated 5-day triple therapy resulted in a significantly lower hospitalization rate and less fatalities with no reported cardiac side effects compared with relevant public reference data of untreated patients,” said Sholz. “The magnitude of the results can substantially elevate the relevance of early use, low dose hydroxychloroquine, especially in combination with zinc. This data can be used to inform ongoing pandemic response policies as well as future clinical trials.”
“It’s unfortunate much of the news coverage surrounding hydroxychloroquine has been negative,” Zelenko added. “This study suggests that when taken early and together with zinc and azithromycin, this cost-effective drug can be part of the solution to the pandemic.”
Triple-drug combo of anti-malaria pill hydroxychloroquine, azithromycin and ZINC improved coronavirus patients’ chances of being discharged and cut death risk by almost 50%, study finds
- Researchers at NYU Grossman School of Medicine looked at 932 coronavirus patients hospitalized between March 2 and April 5
- Half were given a combination of hydroxychloroquine, azithromycin and zinc sulfate and the other half did not receive zinc
- Patients receiving the triple drug combination were 1.5 times more likely to recover enough to be discharged and 44% less likely to die
- The team believes hydroxychloroquine helps zinc, which has antiviral properties, get into infected cells
Combining the anti-malaria drug hydroxychloroquine with the dietary supplement zinc could create a more effective treatment for coronavirus patients, a new study suggests. Researchers found that taking the drugs together, along with the antibiotic azithromycin, increased patient’s chances of being discharged and decreased their risk of dying.
I think I have proven unequivocally that the FDA, Bif Pharma and Dr. Fauci do not have our best interests at heart. They are in it for the money, power and the fame. Having millions of people waiting expectantly for your every word you speak is like an aphrodisiac for some people. Whether or not Hydroxychloroquine, azithormax and zinc work in the treatment of covid-19, is besides the point. Because by limiting our access to these drugs they are quite possibly jeopardizing our health and our very lives because of their campaign.
Dr. Fauci Postings